“Multiway analysis of variance indicated that treatment with pegylated asparaginase (p < 0.001), admission to the intensive care unit (ICU; p = 0.0007), and treatment with albumin, plasma, or coagulation factors (p = 0.01) are potential confounding factors of BG reactivity.”
“Our results also suggest that elevated BG levels in patients treated with pegylated asparaginase , albumin, plasma, or coagulation factors, or those admitted to the ICU should be interpreted with caution.”